Janney Montgomery Scott LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 17.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,529 shares of the company's stock after purchasing an additional 7,994 shares during the quarter. Janney Montgomery Scott LLC's holdings in GE HealthCare Technologies were worth $4,263,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in GEHC. State Street Corp grew its position in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after buying an additional 1,347,114 shares during the last quarter. Geode Capital Management LLC boosted its stake in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock valued at $1,026,898,000 after acquiring an additional 733,819 shares in the last quarter. D1 Capital Partners L.P. purchased a new position in GE HealthCare Technologies in the third quarter worth $268,159,000. Charles Schwab Investment Management Inc. increased its position in shares of GE HealthCare Technologies by 12.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company's stock worth $254,422,000 after purchasing an additional 290,019 shares in the last quarter. Finally, Van ECK Associates Corp purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $208,513,000. 82.06% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $96.00.
Read Our Latest Research Report on GEHC
GE HealthCare Technologies Stock Performance
Shares of NASDAQ:GEHC traded down $0.77 during midday trading on Monday, reaching $87.53. The company's stock had a trading volume of 1,313,880 shares, compared to its average volume of 2,631,187. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a fifty day moving average of $82.87 and a 200 day moving average of $85.04. GE HealthCare Technologies Inc. has a twelve month low of $72.61 and a twelve month high of $94.55. The firm has a market capitalization of $39.99 billion, a PE ratio of 24.07, a P/E/G ratio of 2.92 and a beta of 1.14.
GE HealthCare Technologies Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.85%.
Insider Buying and Selling at GE HealthCare Technologies
In other news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.27% of the company's stock.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
